FibroGen Inc

NASDAQ:FGEN   12:02:00 PM EDT
13.11
-0.16 (-1.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.21B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$71.38 Million
Adjusted EPS-$0.45
See more estimates
10-Day MA$16.57
50-Day MA$22.88
200-Day MA$34.40
See more pivots

FibroGen Inc Stock, NASDAQ:FGEN

409 Illinois Street, San Francisco, California 94158
United States of America
Phone: +1.415.978.1200
Number of Employees: 599

Description

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.